MENU

  • freehdpornaccess.com
  • hq-teens.com
  • 3redlightfix.com
  • omegajeans.com.br
  • ardyssbodymagic.ca
  • orly.ch
  • renqun.com
  • boletomail.com.br
  • amoeba.pl
  • edruck.ch
  • radixdvd.com
  • dreambsys.com
  • cobrared.cl
  • boletomail.com.br
  • deutschecasinos.com
  • mtech2011.com
  • atomicmedia.ca
  • musikalessons.com
  • myfavouritepubwalks.com
  • gamegen.com.br

    • last data update: 2011/10/13, 23:49

    Website loading time

    during the test: 0.4 s

    cable connection (average): 0.5 s

    DSL connection (average): 0.6 s

    modem (average): 5.89 s

    HTTP headers

    HTTP/1.1 301 Moved Permanently

    Date: Fri, 14 Oct 2011 06:49:33 GMT

    Server: Apache/2.0.63 (Unix) mod_ssl/2.0.63 OpenSSL/0.9.8e-fips-rhel5 mod_auth_passthrough/2.1 mod_bwlimited/1.4 FrontPage/5.0.2.2635 PHP/5.3.3

    Location: http://www.parexel.com/

    Content-Length: 231

    Connection: close

    Content-Type: text/html; charset=iso-8859-1

    HTTP/1.1 200 OK

    Date: Fri, 14 Oct 2011 06:49:33 GMT

    Server: Apache/2.0.63 (Unix) mod_ssl/2.0.63 OpenSSL/0.9.8e-fips-rhel5 mod_auth_passthrough/2.1 mod_bwlimited/1.4 FrontPage/5.0.2.2635 PHP/5.3.3

    X-Powered-By: PHP/5.3.3

    Set-Cookie: CONCRETE5=18c679c75e5c52153e31aca6bcff597b; path=/

    Expires: Thu, 19 Nov 1981 08:52:00 GMT

    Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0

    Pragma: no-cache

    Connection: close

    Content-Type: text/html

    Information about DNS servers

    parexel.comA50.28.8.201IN43200
    parexel.comMX10mimir.parexel.comIN43200
    parexel.comMX10norse.parexel.comIN43200
    parexel.comSOAcliff.parexel.comdaniel.gilbride.parexel.com201114100128800 1800 1209600 3600 IN 43200
    parexel.comTXTv=spf1 ip4:12.189.204.39 ip4:193.102.79.160 ip4:195.153.223.130 ip4:81.144.138.117 ip4:62.232.208.174 ip4:62.232.208.175 ip4:206.132.28.19 ip4:206.132.28.20 ip4:195.99.156.254 ip4:206.132.28.88 a:smtp1.vovici.com a:smtp2.vovici.com include:vovici.com ~allArrayIN43200
    parexel.comNSnewman.parexel.deIN43200
    parexel.comNScliff.parexel.comIN43200
    parexel.comNScobalt.parexel.comIN43200

    Received from the first DNS server

    Request to the server "parexel.com"
    You used the following DNS server:
    DNS Name: newman.parexel.de
    DNS Server Address: 195.127.43.174#53
    DNS server aliases:

    HEADER opcode: REQUEST, status: NOERROR, id: 49616
    flag: qr aa rd REQUEST: 1, ANSWER: 8, AUTHORITY: 0, ADDITIONAL: 1

    REQUEST SECTION:
    parexel.com. IN ANY

    ANSWER SECTION:
    parexel.com. 43200 IN SOA cliff.parexel.com. daniel.gilbride.parexel.com. 2011280901 28800 1800 1209600 3600
    parexel.com. 43200 IN A 50.28.8.201
    parexel.com. 43200 IN MX 10 norse.parexel.com.
    parexel.com. 43200 IN MX 10 mimir.parexel.com.
    parexel.com. 43200 IN NS newman.parexel.de.
    parexel.com. 43200 IN NS cliff.parexel.com.
    parexel.com. 43200 IN NS cobalt.parexel.com.
    parexel.com. 43200 IN TXT "v=spf1 ip4:12.189.204.39 ip4:193.102.79.160 ip4:195.153.223.130 ip4:81.144.138.117 ip4:62.232.208.174 ip4:62.232.208.175 ip4:206.132.28.19 ip4:206.132.28.20 ip4:195.99.156.254 ip4:206.132.28.88 a:smtp1.vovici.com a:smtp2.vovici.com include:vovici.com ~all"

    SECTION NOTES:
    mimir.parexel.com. 43200 IN A 12.189.204.39

    Received 497 bytes from address 195.127.43.174#53 in 111 ms

    Received from the second DNS server

    Request to the server "parexel.com"
    You used the following DNS server:
    DNS Name: cliff.parexel.com
    DNS Server Address: 12.104.6.170#53
    DNS server aliases:

    HEADER opcode: REQUEST, status: NOERROR, id: 40532
    flag: qr aa rd REQUEST: 1, ANSWER: 8, AUTHORITY: 0, ADDITIONAL: 1

    REQUEST SECTION:
    parexel.com. IN ANY

    ANSWER SECTION:
    parexel.com. 43200 IN TXT "v=spf1 ip4:12.189.204.39 ip4:193.102.79.160 ip4:195.153.223.130 ip4:81.144.138.117 ip4:62.232.208.174 ip4:62.232.208.175 ip4:206.132.28.19 ip4:206.132.28.20 ip4:195.99.156.254 ip4:206.132.28.88 a:smtp1.vovici.com a:smtp2.vovici.com include:vovici.com ~all"
    parexel.com. 43200 IN SOA cliff.parexel.com. daniel.gilbride.parexel.com. 2011141001 28800 1800 1209600 3600
    parexel.com. 43200 IN NS cobalt.parexel.com.
    parexel.com. 43200 IN NS newman.parexel.de.
    parexel.com. 43200 IN NS cliff.parexel.com.
    parexel.com. 43200 IN MX 10 norse.parexel.com.
    parexel.com. 43200 IN MX 10 mimir.parexel.com.
    parexel.com. 43200 IN A 50.28.8.201

    SECTION NOTES:
    cliff.parexel.com. 43200 IN A 12.104.6.170

    Received 497 bytes from address 12.104.6.170#53 in 16 ms

    Subdomains (the first 50)

    eumailjobs

    Typos (misspells)

    oarexel.com
    larexel.com
    -arexel.com
    0arexel.com
    pzrexel.com
    psrexel.com
    pwrexel.com
    pqrexel.com
    paeexel.com
    padexel.com
    pafexel.com
    patexel.com
    pa5exel.com
    pa4exel.com
    parwxel.com
    parsxel.com
    pardxel.com
    parrxel.com    		par4xel.com
    par3xel.com
    parezel.com
    parecel.com
    paredel.com
    paresel.com
    parexwl.com
    parexsl.com
    parexdl.com
    parexrl.com
    parex4l.com
    parex3l.com
    parexek.com
    parexep.com
    parexeo.com
    arexel.com
    prexel.com
    paexel.com    		parxel.com
    pareel.com
    parexl.com
    parexe.com
    aprexel.com
    praexel.com
    paerxel.com
    parxeel.com
    pareexl.com
    parexle.com
    pparexel.com
    paarexel.com
    parrexel.com
    pareexel.com
    parexxel.com
    parexeel.com
    parexell.com

    Location

    IP: 50.28.8.201

    continent: NA, country: United States (USA), city: Lansing

    Website value

    rank in the traffic statistics: 209 695

    page wievs - daily average: 1 032

    page views - monthly average: 30 969

    visitors - daily average during last 30 days: 111

    visitors during last 30 days: 3 330

    estimated daily income from ads: 15 USD

    estimated monthly income from ads: 450 USD

    estimated website value: 14 994 USD

    Basic information

    website build using CSS

    code weight: 38.46 KB

    text per all code ratio: 23 %

    title: PAREXEL International – Pharmaceutical Clinical Research Organization, CRO

    description: PAREXEL International is a contract research organization with a focus in pharmaceutical research consulting, clinical research, medical communications, and clinical technology.

    keywords: Clinical Trials, Pharmaceutical Development, Pharmaceutical Consulting, Pharmaceutical Research, Contract Research Organization. CRO, PAREXEL, Clinical Research, Clinical Trial Management, Clinical Research Organization, IVRS, EDC, CTMS, Medical Imaging

    encoding: UTF-8

    language: en

    Website code analysis

    one word phrases repeated minimum three times

    two word phrases repeated minimum three times

    three word phrases repeated minimum three times

    B tags

    U tags

    I tags

    images

    file namealternative text
    jp_flag.jpgPAREXEL Japan
    sb_locate.jpgLocate a Pharmaceutical Consulting Partner
    sb_reflib.jpgPharmaceutical Development Library
    sb_career.jpgPAREXEL Career Center
    cder_minibanner.jpgPAREXEL Executive Briefings: CDER new drug review outcomes and trends
    PAREXEL_home_mini_docs.jpgInvestigator Recruitment

    headers

    H1

    H2

    Find solutions

    The PAREXEL difference

    About

    Services and capabilities

    Clinical stages

    Therapies

    Technology

    Business Challenges

    H3

    Find solutions

    The PAREXEL difference

    About

    Services and capabilities

    Clinical stages

    Therapies

    Technology

    Business Challenges

    H4

    H5

    H6

    internal links

    addressanchor text
    /careers/Careers
    /news-and-events/News and Events
    /index.php?cID=1707Investors
    /ref_lib_overlayPharmaceutical Development Library
    /careers/PAREXEL Career Center
    /
    /business-challenges/Business Challenges
    /business-challenges/strategic-partnering/Strategic partnering
    /business-challenges/biosimilar-development-and-marketing/Biosimilar development and marketing
    /business-challenges/early-sell-or-out-license/Early sell or out-license?
    /business-challenges/acquire-or-partner-develop-market/Acquire or partner, develop, market
    /business-challenges/discover-develop-market/Discover, develop, market
    /business-challenges/acquire-to-distribute/Acquire to distribute
    /business-challenges/manage-product-lifestyle/Manage product lifecycle
    /business-challenges/acquire-develop-and-sell/Acquire, develop, and sell
    /business-challenges/risk-management/Risk management
    /business-challenges/pharmacovigilance/Pharmacovigilance
    /business-challenges/emerging-regions/Emerging Regions
    /clinical-stages/Clinical Stages
    /clinical-stages/phase-i-first-in-man/Early stage studies: Phase I/IIa
    /clinical-stages/phase-ii-proof-of-concept/Pivotal clinical trials: Phase IIb/III
    /clinical-stages/phase-iib/Peri-approval/post-marketing studies: Phase IIIb/IV
    /therapies/Therapy
    /therapies/cardiovascular/Cardiovascular and metabolic diseases
    /therapies/cns/Central nervous system (CNS) disorders
    /therapies/infectious-disease/Infectious disease
    /therapies/oncology/Oncology and hematology
    /therapies/others/Other therapeutic areas
    /about/About
    /about/management-team/Management team
    /about/global-presence/Find an office
    /about/experience-and-expertise/Experience and expertise
    /about/innovative-technology/eClinical innovation
    /about/businesses-we-serve/Businesses we serve
    /about/why-parexel/Why PAREXEL?
    /services-and-capabilities/Services and Capabilities
    /services-and-capabilities/consulting/PAREXEL Consulting
    /services-and-capabilities/early-phase/Early Phase
    /services-and-capabilities/clinical-research/Clinical Research
    /services-and-capabilities/late-phase/Late Phase
    /services-and-capabilities/medical-communications/Medical Communications
    /technology/Technology
    /technology/clinphone-rtsm/ClinPhone RTSM
    /technology/medical-imaging/Imaging
    /technology/clinical-trial-management-systems/CTMS
    /technology/edc/EDC
    /technology/epro/ePRO
    /technology/solutions/Solutions
    http://www.parexel.com/recent/cder-new-drug-review-outcomes-and-trendsPAREXEL Executive Briefings: CDER new drug review outcomes and trends
    /gateway-survey/Investigator Recruitment
    /about/About
    /about/management-team/Management team
    /about/global-presence/Find an office
    /about/experience-and-expertise/Experience and expertise
    /about/innovative-technology/eClinical innovation
    /about/businesses-we-serve/Businesses we serve
    /about/why-parexel/Why PAREXEL?
    /contact-us/Advanced contact
    /news-and-events/News and events
    /services-and-capabilities/Services and capabilities
    /services-and-capabilities/consulting/PAREXEL Consulting
    /services-and-capabilities/early-phase/Early Phase
    /services-and-capabilities/clinical-research/Clinical Research
    /services-and-capabilities/late-phase/Late Phase
    /services-and-capabilities/medical-communications/Medical Communications
    /clinical-stages/Clinical stages
    /clinical-stages/phase-i-first-in-man/Early stage studies: Phase I/IIa
    /clinical-stages/phase-ii-proof-of-concept/Pivotal clinical trials: Phase IIb/III
    /clinical-stages/phase-iib/Peri-approval/post-marketing studies: Phase IIIb/IV
    /therapies/Therapies
    /therapies/cardiovascular/Cardiovascular and metabolic diseases
    /therapies/cns/Central nervous system (CNS) disorders
    /therapies/infectious-disease/Infectious disease
    /therapies/oncology/Oncology and hematology
    /therapies/others/Other therapeutic areas
    /technology/Technology
    /technology/clinphone-rtsm/ClinPhone RTSM
    /technology/medical-imaging/Imaging
    /technology/clinical-trial-management-systems/CTMS
    /technology/edc/EDC
    /technology/epro/ePRO
    /technology/solutions/Solutions
    /business-challenges/Business Challenges
    /business-challenges/strategic-partnering/Strategic partnering
    /business-challenges/biosimilar-development-and-marketing/Biosimilar development and marketing
    /business-challenges/early-sell-or-out-license/Early sell or out-license?
    /business-challenges/acquire-or-partner-develop-market/Acquire or partner, develop, market
    /business-challenges/discover-develop-market/Discover, develop, market
    /business-challenges/acquire-to-distribute/Acquire to distribute
    /business-challenges/manage-product-lifestyle/Manage product lifecycle
    /business-challenges/acquire-develop-and-sell/Acquire, develop, and sell
    /business-challenges/risk-management/Risk management
    /business-challenges/pharmacovigilance/Pharmacovigilance
    /business-challenges/emerging-regions/Emerging Regions
    /index.php/contact-us/Contact Us
    /index.php/privacy-policy/Privacy Policy

    external links

    addressanchor text
    http://www.parexel.co.jp/PAREXEL Japan
    http://www.parexel-akademie.de/PAREXEL Akademie
    http://www.parexel-akademie.de/PAREXEL Akademie